5 Best Small-Cap Healthcare Stocks To Buy Now

2. Fate Therapeutics, Inc. (NASDAQ:FATE)

Number of Hedge Fund Holders: 28

Market Capitalization as of December 12: $1.837 Billion

Fate Therapeutics, Inc. (NASDAQ:FATE) is a California-based clinical-stage biopharmaceutical company that develops programmed cellular immunotherapies for cancer and immune disorders worldwide. On November 16, Citi analyst Yigal Nochomovitz maintained a Buy recommendation on Fate Therapeutics, Inc. (NASDAQ:FATE) but lowered the price target on the shares to $80 from $87. The analyst updated his model following the Q3 results.

According to Insider Monkey’s Q3 data, Fate Therapeutics, Inc. (NASDAQ:FATE) was part of 28 hedge fund portfolios, compared to 23 in the prior quarter. Jeremy Green’s Redmile Group is the largest stakeholder of the company, with approximately 13 million shares worth $290.3 million. It is one of the best small-cap healthcare stocks to invest in as per smart hedge funds. 

Follow Fate Therapeutics Inc (NASDAQ:FATE)